Avidity Biosciences, Inc.
| Security | RNA / Avidity Biosciences, Inc. |
| Insider | Teresa McCarthy |
This page shows the track record and history of McCarthy Teresa
insider trades in Avidity Biosciences, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Teresa McCarthy in RNA / Avidity Biosciences, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Teresa McCarthy in RNA / Avidity Biosciences, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-17 | 2025-09-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 41.4095 | -15,000 | -621 | 97,130 | ||||
| 2025-09-17 | 2025-09-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 22.3400 | 15,000 | 335 | 112,130 | ||||
| 2025-08-15 | 2025-08-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 46.5632 | -10,000 | -466 | 97,130 | ||||
| 2025-08-15 | 2025-08-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 22.3400 | 10,000 | 223 | 107,130 | ||||
| 2025-03-21 | 2025-03-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 31.0598 | -7,778 | -242 | 97,130 | ||||
| 2025-01-23 | 2025-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 28.5968 | -1,221 | -35 | 104,908 | ||||
| 2025-01-23 | 2025-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 28.5931 | -1,738 | -50 | 106,129 | ||||
| 2025-01-08 | 2025-01-06 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25,000 | 107,867 | ||||||
| 2024-12-19 | 2024-12-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 32.6600 | -11,151 | -364 | 82,867 | ||||
| 2024-12-18 | 2024-12-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 33.2642 | -25,000 | -832 | 94,018 | ||||
| 2024-12-18 | 2024-12-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14.2200 | 25,000 | 356 | 119,018 | ||||
| 2024-11-20 | 2024-11-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 41.1408 | -25,000 | -1,029 | 94,018 | ||||
| 2024-11-20 | 2024-11-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14.2200 | 25,000 | 356 | 119,018 | ||||
| 2024-10-17 | 2024-10-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 48.5204 | -25,000 | -1,213 | 94,018 | ||||
| 2024-10-17 | 2024-10-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14.2200 | 25,000 | 356 | 119,018 | ||||
| 2024-09-23 | 2024-09-23 | 4 | McCarthy Teresa | RNA | Common Stock | D | 44.0004 | -13,153 | -579 | 69,018 | ||||
| 2024-09-23 | 2024-09-19 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25,000 | 94,018 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25,000 | 94,018 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | McCarthy Teresa | RNA | Common Stock | D | 40.4017 | -25,000 | -1,010 | 57,171 | ||||
| 2024-09-13 | 2024-09-11 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14.2200 | 25,000 | 356 | 82,171 | ||||
| 2024-06-20 | 2024-06-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 39.1294 | -9,864 | -386 | 32,171 | ||||
| 2024-06-20 | 2024-06-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25,000 | 57,171 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25,000 | 57,171 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | McCarthy Teresa | RNA | Common Stock | D | 10.1300 | -2,065 | -21 | 17,035 | ||||
| 2024-01-23 | 2024-01-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 16,500 | 17,458 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 20,000 | 20,958 | ||||||
| 2022-03-15 | 2022-01-21 | 4 | McCarthy Teresa | RNA | Stock Option (Right to Buy) | D | 14.22 | 157,500 | 157,500 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
